112 related articles for article (PubMed ID: 31378885)
1. LncRNA TATDN1 induces the progression of hepatocellular carcinoma via targeting miRNA-6089.
Shen C; Xu Y; Lu TF; Zhang JJ; Qian YB; Xu N
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6459-6466. PubMed ID: 31378885
[TBL] [Abstract][Full Text] [Related]
2. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
Chen L; Yao H; Wang K; Liu X
J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
[TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.
Li B; Mao R; Liu C; Zhang W; Tang Y; Guo Z
Life Sci; 2018 Mar; 197():122-129. PubMed ID: 29421439
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2.
Gao HB; Gao FZ; Chen XF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5149-5157. PubMed ID: 31298368
[TBL] [Abstract][Full Text] [Related]
8. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
Lin XQ; Huang ZM; Chen X; Wu F; Wu W
Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
[TBL] [Abstract][Full Text] [Related]
10. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
Fan JC; Zeng F; Le YG; Xin L
J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
Li H; Yuan R; Wang H; Li C; Wei J
J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MT1JP inhibits the malignant progression of hepatocellular carcinoma through regulating AKT.
Wu JH; Xu K; Liu JH; Du LL; Li XS; Su YM; Liu JC
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6647-6656. PubMed ID: 32633354
[TBL] [Abstract][Full Text] [Related]
15. LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
Li J; Wang AS; Wang S; Wang CY; Xue S; Guan H; Li WY; Ma TT; Shan YX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1022-1029. PubMed ID: 30779068
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664.
He JH; Han ZP; Liu JM; Zhou JB; Zou MX; Lv YB; Li YG; Cao MR
J Cell Biochem; 2017 Nov; 118(11):3713-3721. PubMed ID: 28374914
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of
Wu G; Ju X; Wang Y; Li Z; Gan X
Cell Cycle; 2019 Aug; 18(16):1849-1867. PubMed ID: 31258024
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]